Aurinia Pharmaceuticals Inc. (AUPH)

Price & Market Data

Price: $15.82

Daily Change: +$0.10 / 0.63%

Daily Range: $15.47 - $16.08

Market Cap: $2,056,340,736

Daily Volume: 1,335,101

Performance Metrics

1 Week: -0.31%

1 Month: -0.44%

3 Months: 9.82%

6 Months: 9.45%

1 Year: 96.92%

YTD: 0.25%

About Aurinia Pharmaceuticals Inc. (AUPH)

Your go-to source for Aurinia Pharmaceuticals Inc. (AUPH) market data. Current price: 15.82, daily change: +$0.10 / 0.63%. Market cap: 2,056,340,736. All essential performance metrics are here, from 1-month to 1-year.

Company Details

Employees: 128

Sector: Health technology

Industry: Biotechnology

Country: Canada

Details

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Selected stocks

MEDIFAST INC (MED)

GE Vernova Inc. (GEV)

Shore Bancshares, Inc. (SHBI)

Senseonics Holdings, Inc. (SENS)

Montauk Renewables, Inc. (MNTK)